Julianne Bruno serves as Executive at CRISPR Therapeutics AG, where they oversee executive responsibilities. Since joining the company, Julianne Bruno has executed 4 insider transactions totaling $188.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 9, 2026 involved exercising options for 129 shares valued at $0.
Julianne Bruno currently holds 137,032 shares of CRISPR Therapeutics AG (CRSP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Julianne Bruno has been a net seller of CRSP stock. They have purchased $0 and sold $188.8K worth of shares.
Julianne Bruno's most recent insider trade was on Feb 9, 2026, when they sold 129 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 21, 2024 | CRSP | $188.8K | Sale | 3,366 | $56.09 | Discretionary |
| Jun 20, 2024 | CRSP | $0 | Option Exercise | 7,000 | $N/A | Discretionary |